News brief
According to FinSMEs, Coherence Neuro has completed a round of financing of USD 45 million, led by Founders Fund and OpenAI Startup Fund, with participation from Lux Capital, VC and others. The funds will be used to advance long-term human trials of brain tumor detection and stimulation technology (8).
Connected profiles
Sources · 1Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
- www.finsmes.com ↗Published Oct 21, 2026
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
据FinSMEs报道，Coherence Neuro完成4500万美元A轮融资，由Founders Fund与OpenAI Startup Fund联合领投，Lux Capital、8VC等参投，资金将用于推进脑肿瘤检测与刺激技术的长期人体试验。